The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development and application of a precision cell-free DNA (cfDNA) minimal residual disease (MRD) test to enable optimized treatment selection in patients with genitourinary (GU) cancers.
 
Derrian Cooley
No Relationships to Disclose
 
Ulka N. Vaishampayan
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Bristol-Myers Squibb/Medarex; Exelixis; Gilead Sciences; Merck Serono; Pfizer; Sanofi/Aventis
Speakers' Bureau - Bayer; Exelixis; Pfizer
Research Funding - Bristol-Myers Squibb; Merck KGaA
 
Samuel Kaffenberger
Consulting or Advisory Role - Clovis Oncology; MDxHealth
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Linda Drnek
No Relationships to Disclose
 
Bryan Johnson
Employment - Strata Oncology
Stock and Other Ownership Interests - Strata Oncology
 
Laura Elaine Lamb
Employment - Strata Oncology
Stock and Other Ownership Interests - Strata Oncology
Consulting or Advisory Role - Beaumont Health
Patents, Royalties, Other Intellectual Property - US WO/2017/173342- Methods for Detecting, Diagnosing and Treating Ulcerative Interstitial Cystitis
 
Nickolay A. Khazanov
Employment - Strata Oncology
Stock and Other Ownership Interests - Strata Oncology
 
Daniel H. Hovelson
Employment - Strata Oncology
 
Kat Kwiatkowski
Employment - Strata Oncology
Stock and Other Ownership Interests - Editas Medicine; Epizyme; Intuitive Surgical; Loxo; Strata Oncology
 
Daniel R. Rhodes
Employment - Strata Oncology
Leadership - Strata Oncology
Stock and Other Ownership Interests - Javelin Oncology; Strata Oncology
Patents, Royalties, Other Intellectual Property - Strata Oncology
 
Scott A. Tomlins
Employment - Strata Oncology
Leadership - Strata Oncology
Stock and Other Ownership Interests - Javelin Oncology; Strata Oncology
Consulting or Advisory Role - Astellas Medivation
Research Funding - Astellas Medivation (Inst)
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a patent issued to Strata Oncology related to MSI determination and checkpoint inhibitor benefit. (Inst); I am a co-inventor on a patent issued to the University of Michigan on ETS gene fusions in prostate and am included in the royalty stream. The diagnostic field of use was licensed to Hologic/Gen-Probe (who sublicensed some rights to Ventana/Roche) and is; I am a co-inventor on a provisional patent filed by Strata Oncology on the Immunotherapy Response Score biomarker. (Inst)
Travel, Accommodations, Expenses - Strata Oncology
 
Khaled Hafez
No Relationships to Disclose
 
Lindsey A. Herrel
No Relationships to Disclose
 
Jeffrey S. Montgomery
Consulting or Advisory Role - Ferring
 
Amy Gursky
No Relationships to Disclose
 
Aaron M. Udager
No Relationships to Disclose
 
Todd Matthew Morgan
Consulting or Advisory Role - Blue Earth Diagnostics; Foundation Medicine; Myovant Sciences; Myriad Genetics; Stratify Genomics; Tempus; TERUMO
Research Funding - GenomeDx (Inst); MDxHealth (Inst); Myriad Genetics (Inst)